Dmitry Balyasny’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,015
Closed -$271K 3261
2025
Q4
$271K Buy
+40,015
New +$280K ﹤0.01% 2771
2025
Q3
Sell
-55,181
Closed -$337K 3243
2025
Q2
$337K Sell
55,181
-46,820
-46% -$311K ﹤0.01% 2444
2025
Q1
$775K Buy
+102,001
New +$852K ﹤0.01% 2105
2024
Q1
Sell
-131,754
Closed -$1.16M 2911
2023
Q4
$1.16M Buy
131,754
+87,392
+197% +$640K ﹤0.01% 1627
2023
Q3
$323K Buy
+44,362
New +$330K ﹤0.01% 1887
2023
Q1
Sell
-11,003
Closed -$30.6K 2957
2022
Q4
$30.6K Buy
+11,003
New +$32.9K ﹤0.01% 2419
2021
Q2
Sell
-26,183
Closed -$270K 2190
2021
Q1
$270K Buy
+26,183
New +$253K ﹤0.01% 1528
2018
Q3
Sell
-63,660
Closed -$288K 1896
2018
Q2
$407K Sell
63,660
-67,790
-52% -$483K ﹤0.01% 1412
2018
Q1
$916K Sell
131,450
-1,648,550
-93% -$19.2M ﹤0.01% 1245
2017
Q4
$22.4M Buy
+1,780,000
New +$21.7M 0.07% 366
2016
Q2
Sell
-14,700
Closed -$128K 1340
2016
Q1
$128K Buy
14,700
+1,940
+15% +$16.1K ﹤0.01% 1182
2015
Q4
$120K Sell
12,760
-2,190
-15% -$19K ﹤0.01% 1153
2015
Q3
$144K Buy
+14,950
New +$158K ﹤0.01% 1047

Other funds holding MDXG

Dmitry Balyasny's MDXG Position: Q1 2026 in Review

Dmitry Balyasny sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 40,015 shares — an estimated $271K sold.

Dmitry Balyasny first reported a position in MDXG in Q3 2015 and held it in 13 quarters. The position peaked at $22.4M in Q4 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Dmitry Balyasny reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 40,015 MiMedx Group shares in Q1 2026, an estimated $271K.
  • Dmitry Balyasny first reported a position in MiMedx Group in Q3 2015 and held it in 13 quarters.
  • Dmitry Balyasny's MiMedx Group position peaked at $22.4M in Q4 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.